Travere Therapeutics, Inc.
TVTX
$14.50
$1.017.49%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -60.26M | -54.81M | -70.41M | -136.06M | -90.17M |
| Total Depreciation and Amortization | 12.09M | 11.24M | 10.35M | 9.88M | 9.49M |
| Total Amortization of Deferred Charges | 1.73M | -- | -- | -- | 1.72M |
| Total Other Non-Cash Items | 3.33M | 7.80M | 80.56M | 10.12M | 1.39M |
| Change in Net Operating Assets | 7.40M | -6.74M | -60.74M | -2.95M | 7.10M |
| Cash from Operations | -35.72M | -42.51M | -40.24M | -119.01M | -70.47M |
| Capital Expenditure | 82.00K | 0.00 | -82.00K | -- | 643.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -80.39M | 46.13M | 28.69M | 104.90M | -17.59M |
| Cash from Investing | -80.31M | 46.13M | 28.61M | 104.90M | -16.95M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 148.64M | 571.00K | 1.31M | -- | 13.51M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.53M | -525.00K | -525.00K | -525.00K | -13.38M |
| Cash from Financing | 139.12M | 46.00K | 782.00K | -525.00K | 124.00K |
| Foreign Exchange rate Adjustments | -964.00K | 453.00K | -109.00K | -293.00K | 1.23M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.13M | 4.12M | -10.96M | -14.93M | -86.07M |
